Kezar Life Sciences, Inc. (Nasdaq: KZR), the stock soared 17.65% to $6.5 in the after-hours session following the biotechnology firm disclosed that it was added to the NASDAQ Biotech Index (Nasdaq: NBI), effective before market opening on Monday 21 December 2020.
The NASDAQ Biotechnology Index is intended to measure stocks’ success traded on the Nasdaq Stock Exchange (Nasdaq), categorized under the Industry Classification Benchmark as either biotechnology or pharmaceutical (ICB). Under an updated capitalization-weighted algorithm, the NASDAQ Biotechnology Index is calculated.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
NASDAQ Biotechnology Index firms must meet eligibility rules, including minimum market capitalization, estimated daily trading volume and, among other factors, seasoning as a public company. In December, Nasdaq selects constituents once per annum. For more information about the NASDAQ.
